Author Archives: Jon C. Ogg

Follow Jon here:
Google+
burning cash

StemCells Reminds Investors the Lessons of Outright Implosion

StemCells, Inc. (NASDAQ: STEM) just reminded investors and speculators alike just how dangerous it can be to invest in biotech and biohealth companies. The company issued a press release signaling ...
Read Full Story »
Services for the elderly copy

AC Immune Files for IPO, Targeting Alzheimer’s and Parkinson’s

A company called AC Immune has just filed its F-1 paperwork with the U.S. Securities & Exchange Commission (SEC) to pursue an initial public offering (IPO). The filing is for up ...
Read Full Story »

As SodaStream Gets Into Beer: More Than Meets the Eye — or Less?

SodaStream International Ltd. (NASDAQ: SODA) went from a high-growth niche domination company to a company that had a harder time growing. Now the company is seeking to cash in beyond flavored ...
Read Full Story »
warehouse

ISM-Chicago Shows Purchasing Managers Seeing Contraction

Among the slew of economic reports on Tuesday was the ISM-Chicago's Chicago Business Barometer for the month of May. This index fell 1.1 points to 49.3, a signal of slight ...
Read Full Story »
Help wanted sign

How Friday’s Payrolls Report Could Skew Fed Rate Hike Expectations

Friday, June 3, 2016, will mark one of the most important economic readings of this summer. The U.S. Department of Labor will release its report on nonfarm payrolls, private sector ...
Read Full Story »
Welder

Dallas Fed Manufacturing Indexes Went Negative in May

The Federal Reserve Bank of Dallas released the regional Dallas Fed Business Activity reading for May, showing a drop to −20.8 from a less negative −13.9 from April. The Manufacturing Production Index ...
Read Full Story »
Shoppers

Consumer Confidence Drops Again in May

Consumer confidence managed to drop in May. The Conference Board survey showed that consumer confidence fell to 92.6 for the month. Bloomberg had a consensus estimate of 97.0 and Dow Jones was ...
Read Full Story »
Credit cards

Credit Managers Index Shows Slowing Growth in April

The National Association of Credit Management (NACM) has released its Credit Managers Index (CMI) for the month of May. While the index did decline, it was shown to have remained ...
Read Full Story »
stock certificate

Why Even a $100 Million Stock Buyback Matters for Office Depot

Office Depot Inc. (NASDAQ: ODP) may be reeling from the letdown after its failed acquisition by Staples Inc. (NASDAQ: SPLS). Well, the company is not sitting around twiddling its thumbs trying ...
Read Full Story »
Money close-up

Personal Spending Outpaced Income Gains in April

Personal income and consumer spending posted gains for the month of April. Personal income rose by 0.4% in April, meeting the consensus expectations from both Bloomberg and Dow Jones. Where ...
Read Full Story »
buy sell stocks

Top Analyst Upgrades and Downgrades: Cliffs, Deere, Lockheed Martin, Micron, Zillow and Many More

Stocks have mostly been indicated to open in positive territory in the United States on Tuesday after a three-day weekend. Last week saw handy gains, and oil briefly hit $50 ...
Read Full Story »
thumbs up

7 Major Analyst Upgrades Too Big to Ignore

The stock market had a solid week, and the notion of "sell in May and go away" seems to have not prevailed so far in 2016. Investors keep proving that ...
Read Full Story »
buy now

8 Oil and Gas Stocks Analysts Still Want You to Buy

The week of May 27 brought a welcome sign for the oil bulls. That would be the return to $50 oil, no matter how brief that price was seen. It ...
Read Full Story »
Technology

7 Key Tech Stock Upgrades for Big Implied Upside

This past week marked one of the stronger weeks in the stock market. Many technology stocks also participated in the gains. So much for "sell in May and go away," ...
Read Full Story »
biotech word cloud

8 Speculative Biotech and Biohealth Stocks With Major Analyst Upside Calls

May looked as though it was ignoring the "Sell in May and go away!" mantra. Biotech investors also had to absorb many political jabs over drug pricing, as well as ...
Read Full Story »